Array Biopharma, Inc. (ARRY) Posts Q3 Loss of 20c/Share
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $7.77 +4.30%
Revenue Growth %: -11.6%
Financial Fact:
Interest income: 70K
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: -11.6%
Financial Fact:
Interest income: 70K
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Array Biopharma, Inc. (NASDAQ: ARRY) reported Q3 EPS of ($0.20), $0.01 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $7.8 million versus the consensus estimate of $9.4 million.
For earnings history and earnings-related data on Array Biopharma, Inc. (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist
- United Community Banks sells equipment finance unit for $1.9 billion
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
